Moderated By: Tony Chapman
The cannabis industry is evolving rapidly—across borders, business models, and regulatory frameworks. In this four-part session, experts tackle some of the sector’s most pressing topics, from market data chaos to tax reform and international pricing trends. Learn how AI is bringing clarity to cannabis data, why Canada’s excise tax model may need a rethink, and what’s driving wholesale prices in global and German markets. Whether you’re chasing efficiency, profitability, or new markets, this session delivers grounded insights backed by data—not hype. If time permits, the session will conclude with a Q&A.
The High Bar: Wholesale Market Momentum – Canadian and Global Pricing Outlook – An insightful look into the latest trends in cannabis wholesale pricing across Canada and key global markets. This session offers insight into shifting supply-demand dynamics, pricing volatility, and what to expect from emerging international trade flows in 2025. (Presented By: Erin Butler)
Insights into the German Market: Pricing, Portfolios & Key Players – This presentation explores current pricing trends in the German market, highlights leading importer and distributor portfolios, and identifies key licence holders and major brands shaping the landscape. (Presented By: Chris Liddy)
Data High: Standardizing the Chaos in Cannabis – The cannabis industry is overflowing with data, but much of it is fragmented, inconsistent, and frankly, a bit of a buzzkill. In this data-packed session, Neobi reveals how its AI-powered platform unifies the mess. Discover how a standardized data model and advanced API integration are helping leading players clean, structure, and extract gold from the chaos. We’ll share market insights, consumer patterns, and bold predictions; all backed by real data, not smoke. Come for the charts, stay for the clarity. (Presented By: Michael Colbourne)
Excise Tax Study Summary – As the Canadian cannabis industry faces an inflection point with financial viability of cannabis producers in question and following the Health Canada Cannabis Act Review in 2024, we look to a topic that impacts both the financial objectives of cannabis producers and the policy objectives of federal / provincial regulators – the cannabis excise tax. With this article, Deloitte and Cannabis Council of Canada aim to illustrate the financial impact of the cannabis excise tax and provide actionable insights to both cannabis producers and regulators. (Presented By: Christopher McGrath)
